UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9674, pp. 1532 - 1542
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Epidemiology | Humans | Middle Aged | Erythropoietin - adverse effects | Male | Antineoplastic Agents - therapeutic use | Recombinant Proteins | Young Adult | Neoplasms - complications | Anemia - drug therapy | Adult | Female | Anemia - etiology | Effect Modifier, Epidemiologic | Hematinics - therapeutic use | Erythrocyte Transfusion | Proportional Hazards Models | Neoplasms - mortality | Hematinics - adverse effects | Linear Models | Survival Rate | Treatment Outcome | Neoplasms - drug therapy | Randomized Controlled Trials as Topic | Adolescent | Aged | Research Design | Prevention | Complications and side effects | Care and treatment | Anemia | Research | Comparative analysis | Blood transfusion | Health aspects | Risk factors | Erythropoietin, Recombinant | Cancer | Studies | Clinical trials | Radiation therapy | Mortality | Meta-analysis | Index Medicus | Abridged Index Medicus
Journal Article
Cochrane library, ISSN 1469-493X, 2012, Volume 2012, Issue 12, pp. CD003407 - CD003407
Hypertension | Erythropoietin | Anemia | Erythrocyte Transfusion | Recombinant Proteins | Cause of Death | Neoplasms | Randomized Controlled Trials as Topic | Haematopoetic growth factors | Blood disorders | Quality of Life | Darbepoetin alfa | Thromboembolism | Medicine General & Introductory Medical Sciences | Haematological malignancies | Cancer | Haematopoietic Growth Factors | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recombinant Proteins - therapeutic use | Thromboembolism - chemically induced | Erythropoietin - therapeutic use | Humans | Erythropoietin - adverse effects | Anemia - prevention & control | Recombinant Proteins - adverse effects | Erythropoietin - analogs & derivatives | Neoplasms - complications | Anemia - drug therapy | Neoplasms - blood | Hypertension - chemically induced | Erythrocyte Transfusion - utilization | Anemia - etiology | Index Medicus
Journal Article
Cochrane library, ISSN 1469-493X, 2009, Volume 2010, Issue 11, pp. CD007303 - CD007303
Hematinics | Erythropoietin | Erythrocyte Transfusion | Anemia | Recombinant Proteins | Neoplasms | Randomized Controlled Trials as Topic | Haematopoetic growth factors | Blood disorders | Child health | Disease‐Free Survival | Epoetin Alfa | Darbepoetin alfa | Medicine General & Introductory Medical Sciences | Haematological malignancies | Cancer | Haematopoietic Growth Factors | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Anemia - mortality | Humans | Erythropoietin - adverse effects | Neoplasms - mortality | Anemia - therapy | Hematinics - adverse effects | Male | Disease-Free Survival | Erythropoietin - analogs & derivatives | Neoplasms - complications | Anemia - complications | Neoplasms - therapy | Adult | Female | Child | Index Medicus
Journal Article